Damora Therapeutics, Inc. (DMRA)
R&D Expenses
$272.42M
TTM · Period ending: · USD

DMRA R&D Expenses
What is r&d expenses?
Research and development spending.
DMRA r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | R&D Expenses (USD) | Change |
|---|---|---|
| 201,187,000 | +3,044.53% | |
| 6,398,000 | −73.08% | |
| 23,770,000 | −50.69% | |
| 48,206,000 | +25.25% | |
| 38,488,000 | +56.28% | |
| 24,627,000 | −32.58% | |
| 36,526,000 | +261.89% | |
| 10,093,000 | — |
Frequently asked questions: DMRA r&d expenses
What is Damora Therapeutics, Inc. (DMRA)'s current r&d expenses?
Damora Therapeutics, Inc. (DMRA)'s latest reported r&d expenses (TTM) is $272.42M as of Sep 30, 2026. Research and development spending.
How much historical r&d expenses data is available for DMRA?
Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare DMRA's r&d expenses to peers or set an alert?
You can open DMRA's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance